Apeiron Investment Group Ltd., 10% Owner at ATAI Life Sciences N.V. (ATAI), bought 272,782 shares at $5.09 ($1.4M) on 2022-04-20, disclosed to the SEC on 2022-05-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.09 | 67,703 | $345K | 25.2% |
| 2 | $5.09 | 67,703 | $345K | 25.2% |
| 3 | $4.95 | 68,688 | $340K | 24.8% |
| 4 | $4.95 | 68,688 | $340K | 24.8% |
| Total | $5.02 avg | 272,782 | $1.4M | 100% |
| Filing → |
| ENHA | BUY | 2026-09-04 | $210K | — | Filing → |
| ENHA | BUY | 2026-08-20 | $2.9M | — | Filing → |
| ENHA | BUY | 2026-08-18 | $330K | — | Filing → |